Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
MED-EL
MED-EL is a global medical technology company specializing in hearing implants and devices. They develop and manufacture products including cochlear implants, middle ear implants and bone conduction systems.
MED-EL is a privately owned company and is run by its co-founder and CEO Ingeborg Hochmair, a scientist and researcher in the field of hearing implants. The company headquarters are in Innsbruck, Austria.
In the mid-1970s, Ingeborg and Erwin Hochmair were research scientists at the Technical University of Vienna, working on the development of cochlear implants. In 1977, the first microelectronic multichannel cochlear implant was implanted by Dr Kurt Burian in Vienna. In 1979, a modified version of that implant enabled a female patient to understand words and sentences without lip-reading via a small, body-worn sound processor used in a quiet environment.
In 1989, the Hochmair’s decided to create their own hearing implant company: MED-EL GmbH. As Erwin Hochmair had been awarded a professorship at the University of Innsbruck, they decided to found the company in the city and hired their first three employees in 1990. In 1991, they developed the world’s first behind-the-ear (BTE) audio processor. Instead of being attached to the body, this audio processor was worn behind the ear in the same way as a conventional hearing aid.
In 1995, MED-EL developed the CIS LINK system: an audio processor that allowed users of the Ineraid implant to use the recently developed CIS sound coding strategy, despite the fact that Ineraid had discontinued further development on their implants.
In 2003, the company acquired the Vibrant Soundbridge, a new type of active middle ear implant pioneered by American inventor Geoffrey Ball. It was MED-EL’s first non-cochlear implant product. Further non-cochlear implant products followed with the Bonebridge active bone conduction implant in 2012 and the Adhear non-surgical bone conduction system in 2017.
MED-EL operates in over 100 countries worldwide including Europe, America, the Middle East, Asia and Australia. There are around 200,000 MED-EL users around the world.
The company opened its own hearing museum, the Audioversum Science Centre, in 2013. The science centre is located in central Innsbruck.
Hub AI
MED-EL AI simulator
(@MED-EL_simulator)
MED-EL
MED-EL is a global medical technology company specializing in hearing implants and devices. They develop and manufacture products including cochlear implants, middle ear implants and bone conduction systems.
MED-EL is a privately owned company and is run by its co-founder and CEO Ingeborg Hochmair, a scientist and researcher in the field of hearing implants. The company headquarters are in Innsbruck, Austria.
In the mid-1970s, Ingeborg and Erwin Hochmair were research scientists at the Technical University of Vienna, working on the development of cochlear implants. In 1977, the first microelectronic multichannel cochlear implant was implanted by Dr Kurt Burian in Vienna. In 1979, a modified version of that implant enabled a female patient to understand words and sentences without lip-reading via a small, body-worn sound processor used in a quiet environment.
In 1989, the Hochmair’s decided to create their own hearing implant company: MED-EL GmbH. As Erwin Hochmair had been awarded a professorship at the University of Innsbruck, they decided to found the company in the city and hired their first three employees in 1990. In 1991, they developed the world’s first behind-the-ear (BTE) audio processor. Instead of being attached to the body, this audio processor was worn behind the ear in the same way as a conventional hearing aid.
In 1995, MED-EL developed the CIS LINK system: an audio processor that allowed users of the Ineraid implant to use the recently developed CIS sound coding strategy, despite the fact that Ineraid had discontinued further development on their implants.
In 2003, the company acquired the Vibrant Soundbridge, a new type of active middle ear implant pioneered by American inventor Geoffrey Ball. It was MED-EL’s first non-cochlear implant product. Further non-cochlear implant products followed with the Bonebridge active bone conduction implant in 2012 and the Adhear non-surgical bone conduction system in 2017.
MED-EL operates in over 100 countries worldwide including Europe, America, the Middle East, Asia and Australia. There are around 200,000 MED-EL users around the world.
The company opened its own hearing museum, the Audioversum Science Centre, in 2013. The science centre is located in central Innsbruck.